Incannex Healthcare Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $0 | $86.0K | $12.0K | $1.9M | $604.9K |
| Cost of Revenue | — | — | — | $912.0K | $450.3K |
| Gross Profit | — | — | — | $985.6K | $154.5K |
| Gross Margin | — | — | — | 51.9% | 25.5% |
| Operating Expenses | |||||
| Research & Development | $5.2M | $10.7M | $12.9M | — | — |
| SG&A Expense | $17.8M | $13.1M | $17.2M | — | — |
| Operating Income | $-23.0M | $-23.8M | $-30.0M | $-11.4M | $-3.9M |
| Operating Margin | — | -27,661.6% | -250,341.7% | -599.3% | -649.6% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $-19.3M | $-46.9M | $-18.4M | $-11.4M | $-3.9M |
| Income Tax Expense | $0 | $0 | $30.0K | — | — |
| Net Income | $-19.3M | $-46.9M | $-18.5M | $-11.4M | $-4.7M |
| Net Margin | — | -54,517.4% | -153,825.0% | -599.3% | -776.6% |
| EPS (Basic) | $-1.66 | $-40.82 | $-0.12 | $-0.12 | $-0.07 |
| EPS (Diluted) | $-1.66 | $-40.82 | $-0.12 | $-0.12 | $-0.06 |
| Shares Outstanding (Basic) | 11.7M | 1.1M | 161.6M | — | — |
| Shares Outstanding (Diluted) | 11.7M | 1.1M | 161.6M | — | — |
| Dividends Per Share | — | — | — | — | — |